Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice.
The role of endogenous opioid peptides and receptors has recently been investigated using knockout mice. Although the affinities of opioid peptides for opioid receptors has been known for many years there is still some uncertainty over which receptor is the endogenous target for each peptide. To address this issue we have studied using quantitative autoradiography the levels of all four opioid receptor subtypes (micro, delta, kappa and opioid receptor-like 1 [ORL1]) in brains sectioned from enkephalin and dynorphin knockouts, as well as from double knockouts. Because receptor up-regulation has been observed when its cognate ligand-peptide is genetically ablated, regional changes in receptor binding in knockout mice may reflect areas where the peptide ligand is tonically active at its receptor or played a role in receptor regulation. In addition, the study aimed to correlate previously observed behaviour in these animals with receptor modulation. Marked region-specific up-regulation of the micro, delta, and kappa opioid receptors but not ORL1 receptors was observed in proenkephalin and prodynorphin knockouts. In proenkephalin knockouts this was most pronounced for the micro- and delta-receptor and in prodynorphin knockouts for the kappa-receptor. Combinatorial double knockouts did not show any changes in addition to those observed in single knockouts. The largest changes were observed in limbic regions and our results suggest that proenkephalin peptides are tonically active at micro and delta-receptors predominantly in these areas. Prodynorphin peptides appear to regulate mostly the kappa-receptor but they are also modulators of micro- and delta-receptors.
Clarke
S
S
Pharmacology Group, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK.
Zimmer
A
A
Zimmer
A M
AM
Hill
R G
RG
Kitchen
I
I
D000818:Animals; D004399:Dynorphins / Q000172:deficiency / Q000235:genetics; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000378:metabolism; D004745:Enkephalins / Q000172:deficiency / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D018847:Opioid Peptides / Q000172:deficiency* / Q000235:genetics; D011485:Protein Binding / Q000502:physiology; D011957:Receptors, Opioid / Q000096:biosynthesis* / Q000235:genetics; D017465:Receptors, Opioid, delta / Q000096:biosynthesis* / Q000235:genetics; D017473:Receptors, Opioid, kappa / Q000096:biosynthesis* / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000096:biosynthesis* / Q000235:genetics; D015854:Up-Regulation / Q000502:physiology; D000094942:Nociceptin Receptor
D004745:Enkephalins; D018847:Opioid Peptides; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004399:Dynorphins; D000094942:Nociceptin Receptor; C000722287:Oprl1 protein, mouse